Atrovent
Ipratropium bromide inhalation is also known by the brand name Atrovent. 1
Brand Name and Formulations
The FDA-approved brand name for ipratropium bromide is Atrovent, manufactured by Boehringer-Ingelheim. 1 This anticholinergic bronchodilator is available in multiple formulations:
- Atrovent nasal spray in 0.03% and 0.06% concentrations for rhinorrhea 1
- Atrovent inhalation solution for nebulization (0.02% solution) 2
- Atrovent metered-dose inhaler (MDI) at 18 mcg per puff 3
Chemical Classification
Ipratropium bromide is chemically described as a quaternary ammonium muscarinic receptor antagonist, structurally related to atropine but with reduced systemic absorption due to its quaternary structure. 1, 2 The generic name "ipratropium bromide" and brand name "Atrovent" are used interchangeably in clinical practice and medical literature.
Combination Products
When combined with albuterol (a short-acting beta-2 agonist), the product is marketed as Combivent or DuoNeb, containing both ipratropium bromide and albuterol in fixed-dose combinations. 3, 4
The term "Atrovent" remains the most widely recognized alternative name for ipratropium bromide inhalation in clinical practice.